Covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease
The incidence and prevalence of inflammatory bowel disease (IBD) are steadily rising worldwide, where the pathogenesis and progression are intrinsically
Category: Supramolecular systems
Polypeptide-Shelled Cyclodextrin-Containers for Intracellular Delivery of Membrane-Impermeable Cargo
The transport of membrane impermeable compounds into cells is a prerequisite for the efficient cellular delivery of hydrophilic and amphiphilic
Polarization of Stem Cells Directed by Magnetic Field-Manipulated Supramolecular Polymeric Nanofibers
Precise assembly of the cytoskeleton (e.g., actin, tubulin, and intermediate filaments) is of great importance for stem cell polarization and
γ-Cyclodextrin polymers offering alternatives in pharmaceutical and food industry, and environmental remediation
The crystalline cyclic oligosaccharide γ-cyclodextrin (γCD) is a natural, non-toxic and biodegradable precursor that can be used to prepare innovative
Hyperbranched polymers functionalized β-cyclodextrin
Wan et al. (2021) published on the synthesis and potential utilization of β-CD modified with hyperbranced polyglycerol polymer and decorated
The macroscopic shape of assemblies formed from microparticles based on host–guest interaction
Biological macroscopic assemblies have inspired researchers to utilize molecular recognition to develop smart materials in these decades. Recently, macroscopic self-assemblies
Nonviral DNA Delivery System with Supramolecular PEGylation Formed by Host–Guest Pseudo-Block Copolymers
A cationic supramolecular system based on host–guest pseudoblock copolymers was developed for nonviral DNA delivery. In this system, the macromolecular
OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01
Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
Oculis reported positive results from Phase 2 clinical studies of OCS-01 for treating DME
Asymmetric synthesis with cinchona-decorated CD in a continuous-flow membrane reactor
Over the last two decades organocatalysis has become an attractive synthetic tool in asymmetric catalysis. However, the increasing demand for